Risperidone-Paliperidone ER

From Psychiatrienet
Revision as of 16:30, 18 March 2022 by Ken (talk | contribs) (Created page with "<big><span style="color:#ff0000"> * This switch is intended for paliperidone long acting (Xeplion®, 30 days) </span></big> {{Drugswitch | from = Risperidone | to = Paliperi...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

* This switch is intended for paliperidone long acting (Xeplion®, 30 days)

Risperidone
Type antipsychotic
Group atypical AP
Other use moodstabilizer
links
ATC-code N05AX08
Medscape Risperidone
PubChem 5073
PubMed Risperidone
Drugs.com risperidone
Kompas (Dutch) Risperidone
Wikipedia Risperidone
Paliperidone
long acting
Type Antipsychotic
Group Atypical AP
links
Medscape Paliperidone
PubChem 23724979
PubMed Paliperidone
Kompas (Dutch) Paliperidone
Wikipedia Paliperidone

Switch medication from Risperidone to Paliperidone_LA.[4] [5]

Nietinrijdenbord.png Stop Risperidone
  • Day 1: Stop oral risperidone
Eenrichtingbord.png Start Paliperidone_LA
  • Day 1: Start depot according to general dosing advice.
Infobord.png More information
StopOraalOlanStartDepotOlan.jpg
Nietinrijdenbord.png — Risperidone
Eenrichtingbord.png — Paliperidone_LA


  1. 1.0 1.1 KNMP; Informatorium Medicamentorum 2023; Monografie "risperidon" (Dutch)
  2. Woods SW; Chlorpromazine equivalent doses for the newer atypical antipsychotics J Clin Psychiatry 2003;64:663-667
  3. 3.0 3.1 The Lundbeck Institute; Psychotropics; Terminal Plasma Half-lives
  4. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  5. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.